Marc Peschanski

Title: Marc Peschanski: Innovator in Biomedical Research

Introduction

Marc Peschanski is a notable inventor based in Evry, France. He has made significant contributions to the field of biomedical research, particularly in the development of innovative compounds and methods for cellular reprogramming. His work has implications for the treatment and prevention of various diseases.

Latest Patents

Marc Peschanski holds 2 patents that showcase his innovative approach to scientific challenges. His latest patents include "Aminopyridine compounds useful as inhibitors of protein prenylation," which describes a compound for use in the treatment and/or prevention of diseases where inhibition of protein prenylation is required. This patent outlines various configurations of the compound, including those with hydrogen atoms or (C)alkyl groups. Additionally, he has developed a method titled "Reprogrammation of eukaryotic cells with engineered microvesicles." This invention presents a non-genetic, detergent-free, bacteria-free method for reprogramming eukaryotic cells, particularly for obtaining induced pluripotent stem cells (iPS) using engineered microvesicles that carry reprogramming transcription factors.

Career Highlights

Throughout his career, Marc Peschanski has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and the Association Française Contre les Myopathies. His work in these institutions has allowed him to advance his research and contribute to significant scientific advancements.

Collaborations

Marc has collaborated with notable colleagues, including Sophie Blondel and Xavier Nissan. These partnerships have enriched his research and fostered innovation in his projects.

Conclusion

Marc Peschanski is a distinguished inventor whose work in biomedical research continues to impact the field significantly. His innovative patents and collaborations highlight his commitment to advancing scientific knowledge and improving health outcomes.